Navigation Links
EAG Announces General Manager of Environmental Fate, Chemistry and Ecotoxicology (EFCE) Division
Date:3/12/2013

Santa Clara, California (PRWEB) March 12, 2013

2013 Evans Analytical Group (EAG), the world's leading, fully integrated, independent laboratory network, providing high value expert analytical and testing services to a wide range of industries and end users, is pleased to announce Luis Ruzo as the Division General Manager of the EAG Environmental Fate, Chemistry and Ecotoxicology (EFCE) division.

Dr. Ruzo is a seasoned business leader with global experience in these market sectors. The three General Managers of Wildlife, PTRL West, and PTRL Europe will report to Dr. Ruzo. One of his top priorities will be the integration and alignment of Wildlife and PTRL business strategies. He will continue playing a role in exploring new client relationships together with the Division’s business development unit.

Dr. Luis Ruzo comments, “I am excited about taking the leadership role in ECFE Division and my first priority is to communicate to our clients the additional value that they can expect from the unification of the three labs under one Division.”

Prior to joining EAG, Dr. Ruzo served as a Professional Research Chemist and Co-Director of the Pesticide Chemistry and Toxicology Laboratory at the University of California, Berkeley from 1976-87 and then served as Managing Director & CEO of PTRL West from 1988-2012. Additionally, he has served on numerous editorial and advisory boards, including the Canadian National Research Council, EPA's Peer Review Board.

Dr. Ruzo holds a Ph.D. in Organic Chemistry from Michigan State University and conducted post-doctoral work at the University of Guelph and University of Amsterdam (Holland). Throughout his career Dr. Ruzo has focused on the transformations undergone by chemicals in the environment. He has published more than 100 articles in peer reviewed journals as well as giving over 60 presentations at US and international conferences.

Harry Davoody, CEO of EAG, comments, “We are confident that Dr. Ruzo will provide the leadership in cross pollinating the best practices of each of the Labs to make our EFCE Division the preferred development and testing choice for clients.”

About Evans Analytical Group
EAG is the world's leading, fully integrated, independent laboratory network. EAG's Materials Characterization Division provides high value analytical services focused on surface analysis and materials characterization in support of high technology industries. The Company's Release to Production Division provides expert engineering service and support from chip tape-out to volume production in support of the electronics industry. EAG’s Environmental Fate, Chemistry and Ecotoxicology (EFCE) Division provides analytical chemistry, environmental fate, metabolism and eco-toxicology services for agrochemicals, industrial chemicals, pharmaceuticals and animal health products. EAG has an international network of 21 laboratories and sites and serves more than 5,500 customers worldwide. http://www.eaglabs.com

EAG is majority owned by Odyssey Investment Partners, LLC, a leading private equity firm with more than $2 billion in capital under management. Odyssey makes majority, control investments primarily in established middle-market industrial manufacturing and business services companies in a variety of industries. Further information regarding Odyssey Investment Partners can be found at http://www.odysseyinvestment.com.

Read the full story at http://www.prweb.com/releases/analytical/testing/prweb10521155.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2020)... ... March 30, 2020 , ... A joint ... Diagnostics (RID), formed earlier this year to bring telehealth to various government agencies, ... for COVID-19. Company officials are currently?awaiting an Emergency Use Authorization (EUA) waiver from ...
(Date:4/1/2020)... ... March 31, 2020 , ... Carterra® Inc., the world leader ... announced today that they will use Carterra’s proprietary LSA™ platform to screen hundreds of ... clinic as early as this summer. , La Jolla Institute for Immunology (LJI) ...
(Date:3/27/2020)... (PRWEB) , ... March 25, ... ... announces the opening of its veterinary histopathology laboratory located centrally in the ... clients the ability to work with a highly motivated, independent, professional team ...
(Date:3/19/2020)... ... March 17, 2020 , ... RoosterBio ... circuit company Senti Biosciences, Inc. (Senti) to accelerate the clinical translation of ... The collaboration will leverage RoosterBio’s human mesenchymal stem/stromal cell (hMSC) bioprocess systems, ...
Breaking Biology Technology:
(Date:5/6/2020)... ... May 06, 2020 , ... Sickle Cell Disease Association of America, Inc. ... to improving the quality, safety, efficacy and cost of red blood cell (RBC) transfusion ... its mission and meet its goals. In 2020 Hemanext will collaborate with SCDAA on ...
(Date:5/1/2020)... ... April 30, 2020 , ... InBios International Inc., a ... had been awarded a contract from the Biomedical Advanced Research and Development Authority ... at the U.S. Department of Health and Human Services, to develop the SCoV-2 ...
(Date:4/30/2020)... ... 29, 2020 , ... At the start of 2020 ... for a wide range of industries including pharmaceutical and biopharmaceutical manufacturing, healthcare, food ... new decade, it was clear to company leadership that they would have to ...
Breaking Biology News(10 mins):